QC
MRNA icon

Quantessence Capital’s Moderna MRNA Stock Holding History

Quantessence Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$206K Buy
+4,063
New +$190K 1.01% 47
2025
Q2 		– Sell
-31,821
Closed -$902K – 354
2025
Q1 		$902K Sell
31,821
-12,686
-29% -$450K 0.23% 133
2024
Q4 		$1.85M Buy
+44,507
New +$2.13M 0.76% 33

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quantessence Capital's MRNA Position: Q1 2026 in Review

Quantessence Capital opened a new position in Moderna (MRNA) in Q1 2026: 4,063 shares worth $206K. The stake represents 1.01% of the portfolio and ranks #47 among its holdings. This is a return to the name: Quantessence Capital previously reported a position in MRNA as recently as Q1 2025.

Quantessence Capital first reported a position in MRNA in Q4 2024 and has held it in 3 quarters since. The position peaked at $1.85M in Q4 2024. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Quantessence Capital held 4,063 shares of Moderna worth $206K as of Q1 2026.
  • Moderna was a new Quantessence Capital position in Q1 2026.
  • Moderna made up 1.01% of Quantessence Capital's portfolio in Q1 2026, its #47 holding.
  • Quantessence Capital first reported a position in Moderna in Q4 2024 and has held it in 3 quarters since.
  • Quantessence Capital's Moderna position peaked at $1.85M in Q4 2024.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Quantessence Capital's 13F filing for Q1 2026, filed 15 May 2026.